1. Home
  2. CRI vs BHVN Comparison

CRI vs BHVN Comparison

Compare CRI & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$34.48

Market Cap

1.3B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.12

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
BHVN
Founded
1865
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2002
2022

Fundamental Metrics

Financial Performance
Metric
CRI
BHVN
Price
$34.48
$9.12
Analyst Decision
Hold
Buy
Analyst Count
5
14
Target Price
$34.00
$28.85
AVG Volume (30 Days)
1.3M
1.8M
Earning Date
04-24-2026
03-02-2026
Dividend Yield
2.89%
N/A
EPS Growth
N/A
26.08
EPS
2.53
N/A
Revenue
$2,898,426,000.00
N/A
Revenue This Year
$3.02
N/A
Revenue Next Year
$0.77
N/A
P/E Ratio
$13.63
N/A
Revenue Growth
1.91
N/A
52 Week Low
$23.38
$7.48
52 Week High
$44.44
$31.18

Technical Indicators

Market Signals
Indicator
CRI
BHVN
Relative Strength Index (RSI) 42.71 31.99
Support Level $31.90 $8.40
Resistance Level $39.05 $10.28
Average True Range (ATR) 1.75 0.71
MACD -0.25 -0.13
Stochastic Oscillator 50.96 0.36

Price Performance

Historical Comparison
CRI
BHVN

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: